课题基金 / 基金详情

CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)

CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
CK20-004,芝加哥预防和干预中心 III (CPIE-III)
批准号:
10651677
负责人:
Mary Katherine Hayden
金额:
$167.88万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-05-31

项目摘要

项目成果

Mary Katherine Hayden的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core Project Summary The Chicago Prevention and Intervention Epicenter will focus on objectives promoted by CDC. Through our core projects we will make epidemiologic and basic science discoveries and technological innovations translatable into strategies to prevent spread of antimicrobial-resistant organisms within facilities and regionally across the web of interconnected facilities. To control endemic antimicrobial-resistant pathogens, and to mitigate emerging, novel mechanisms of resistance, a bundle of interventions is needed and applied across the spectrum of healthcare facilities. We propose an ambitious portfolio of projects in hospitals, long-term acute care hospitals (LTACHs), and skilled nursing facilities. Our projects span the infection control domains of interest to CDC, annotated by the following six core projects (abridged for this summary): Project 1: Predictive modeling to identify patients at high-risk for MDROs to inform Illinois' XDRO registry. Population, hospital and LTACH patients. Domain, regional control including long-term care facilities. Project 2: Regional active MDRO surveillance with genomic analysis. Population, hospitals, LTACHs and nursing homes. Domain, containment of novel resistance. Project 3: Geospatial, ecologic, and clinical risk factors for community-associated ESBL-producers. Population, emergency department and ambulatory patients of two large, urban health systems. Domain, community-associated antimicrobial-resistant infections. Project 4: Genomic epidemiology of MDRO transmission in ICUs. Population, hospital ICU patients. Domain, applying innovative research methodology to evaluate MDRO transmission. Project 5: Adverse health outcomes associated with microbiota disruption. Population, medical ICU patients. Domains, effects of antibiotic use and diagnostics—evaluating measures of the microbiome. Project 6: Generate and export reports on antimicrobial use metrics from a national common data model. Population, hospital patients. Domain, Antimicrobial stewardship
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
  • 批准号:
    10466708
  • 项目类别:
  • 资助金额:
    $138.75万
  • 财政年份:
    2021
  • 负责人:
    Mary Katherine Hayden
  • 依托单位:
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
  • 批准号:
    10402237
  • 项目类别:
  • 资助金额:
    $169.73万
  • 财政年份:
    2021
  • 负责人:
    Mary Katherine Hayden
  • 依托单位:
Chicago Prevention and Intervention Epicenter II (CPIE-II)
  • 批准号:
    9338037
  • 项目类别:
  • 资助金额:
    $49.88万
  • 财政年份:
    2016
  • 负责人:
    Mary Katherine Hayden
  • 依托单位:
Chicago Prevention and Intervention Epicenter II (CPIE-II)
  • 批准号:
    10192603
  • 项目类别:
  • 资助金额:
    $60.0万
  • 财政年份:
    2016
  • 负责人:
    Mary Katherine Hayden
  • 依托单位:
国内基金
海外基金
新型蒽酚类化合物XYD004通过激活AHR缓解银屑病的作用及机制研究
  • 批准号:
    2025JJ60573
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    蒋骞
  • 依托单位:
tiRNA-Val-TAC-004在胃癌进展中的作用机制及标志物价值研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    付敏
  • 依托单位:
环状RNA hsa_circSERPINE2_004介导MSC衰老在老年性骨质 疏松症发病中的作用及其机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    旺姗
  • 依托单位:
ADRQβ-004疫苗靶向α1D-AR调节交感神经失衡与改善肺动脉重构的机制研究
  • 批准号:
    82070522
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    邱志华
  • 依托单位: